SRDX surmodics.com Market Cap to Net Assets Ratio

Official company branding of Surmodics Inc (SRDX)

This chart of trading activity on GURU.Markets helps assess the resilience of Surmodics, Inc. (SRDX), which is protected by stringent FDA requirements and proprietary copyrights for specialized coatings. The current indicator stands at 5.54, while management revises its strategic direction, relying on shareholder confidence. Surmodics, Inc. (SRDX) generates revenue by creating indispensable hydrophilic layers that enhance the effectiveness of vascular therapy instruments for global manufacturers.

SRDX Surmodics Inc.: Market Value to Book Value in the range 07/04/2022 - 11/29/2025
Original product of Surmodics Inc

This indicator measures the premium of a business's market value over its net assets, allowing for an assessment of the extent to which the stock price is inflated relative to actual capital. By analyzing the ratio of the current market price of Surmodics, Inc. (SRDX) to its book net assets, an investor can see the capitalization of unique B2B technologies that generate high value through customers' technological dependence on proprietary coatings.

Competitor analysis

Market Cap to Net Assets Ratio DexCom, Inc.|Capitalization to Book Value Ratio penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value Procept (PRCT)|CNMD: Market Capitalization to Book Value Ratio|pulsebiosciences.com - Market-to-Book Ratio|Market Value to Book Value Ratio InMode (INMD)|PMI - Market Value to Book Value|SENS: Market Capitalization to Book Value Ratio|NPCE (NeuroPace Medical) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Tactile Systems Technology, Inc. TCMD|Market Capitalization to Net Assets sanuwave.com|Outset Medical - Market Capitalization to Book Value Ratio|Market-to-Book Ratio smartvest.com ELMD|Market Cap to Net Assets Ratio LNSR (LENSAR, Inc)|RCEL - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Profound Medical Corporation PROF|BDMD - Market Cap to Book Value Multiple|edap-tms.com - Market Capitalization to Book Value Ratio|Apyx Medical Corporation (APYX) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ICCM|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|TELA Bio, Inc. (TELA) - Market Cap to Net Assets Ratio|Market Value to Book Value CTSO (cytosorbents.com)|Sensus Healthcare - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Zynex Medical ZYXI|ECOR (electroCore Medical) - Market Capitalization to Book Value Ratio|RBOT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio inspira-technologies.com|seastarmedical.com (ICU) - Capitalization to Book Value Ratio|IRIX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Intelligent Bio|Market Capitalization to Book Value Ratio XAIR (Beyond Air, Inc.)|Market Cap to Net Assets Ratio Profusa, Inc (PFSA)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)